Cargando…

Transgenic Rabbit Models in Proarrhythmia Research

Drug-induced proarrhythmia constitutes a potentially lethal side effect of various drugs. Most often, this proarrhythmia is mechanistically linked to the drug's potential to interact with repolarizing cardiac ion channels causing a prolongation of the QT interval in the ECG. Despite sophisticat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baczkó, István, Hornyik, Tibor, Brunner, Michael, Koren, Gideon, Odening, Katja E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291951/ https://www.ncbi.nlm.nih.gov/pubmed/32581808 http://dx.doi.org/10.3389/fphar.2020.00853

Ejemplares similares

Transgenic LQT2, LQT5, and LQT2‐5 rabbit models with decreased repolarisation reserve for prediction of drug‐induced ventricular arrhythmias
por: Hornyik, Tibor, et al.
Publicado: (2020)

Pronounced Effects of HERG-Blockers E-4031 and Erythromycin on APD, Spatial APD Dispersion and Triangulation in Transgenic Long-QT Type 1 Rabbits
por: Ziupa, David, et al.
Publicado: (2014)

A computational model of rabbit geometry and ECG: Optimizing ventricular activation sequence and APD distribution
por: Moss, Robin, et al.
Publicado: (2022)

Proarrhythmia associated with antiarrhythmic drugs: a comprehensive disproportionality analysis of the FDA adverse event reporting system
por: Wang, Feifei, et al.
Publicado: (2023)

The Effects of SEA0400 on Ca(2+) Transient Amplitude and Proarrhythmia Depend on the Na(+)/Ca(2+) Exchanger Expression Level in Murine Models
por: Bögeholz, Nils, et al.
Publicado: (2017)

Non-invasive monitoring of changes in rabbit hearts with aging using MR microscocpy
por: Hwang, Min-Sig, et al.
Publicado: (2011)

Assessment of the proarrhythmic effects of repurposed antimalarials for COVID-19 treatment using a comprehensive in vitro proarrhythmia assay (CiPA)
por: Yoon, Seung-Hyun, et al.
Publicado: (2023)

Normalization of QT interval duration in a long QT syndrome patient during pregnancy and the postpartum period due to sex hormone effects on cardiac repolarization
por: Odening, Katja E., et al.
Publicado: (2016)

Proarrhythmia Induced by Propafenone: What is the Mechanism?
por: Femenia, Francisco, et al.
Publicado: (2010)

Proarrhythmia and Oncotherapy: So Much To Be Done!
por: Kovacs, Richard J.
Publicado: (2021)

In vivo KCNQ1-suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome
por: Giammarino, L, et al.
Publicado: (2023)

Optimization of an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment
por: Dutta, Sara, et al.
Publicado: (2017)

Proarrhythmia in a Patient With Heart Failure on Therapy With Amiodarone
por: Semerdzhieva, Niya E, et al.
Publicado: (2021)

Oxytocin exerts harmful cardiac repolarization prolonging effects in drug-induced LQTS
por: Kreifels, Paul, et al.
Publicado: (2022)

Corrigendum: Optimization of an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment
por: Dutta, Sara, et al.
Publicado: (2017)

MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia
por: Uddin, Muhammad Erfan, et al.
Publicado: (2022)

Early Drug Discovery Prediction of Proarrhythmia Potential and Its Covariates
por: Polak, Sebastian, et al.
Publicado: (2015)

Uncertainty assessment of proarrhythmia predictions derived from multi-level in silico models
por: Kopańska, Karolina, et al.
Publicado: (2023)

Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA Initiative
por: Li, Zhihua, et al.
Publicado: (2018)

General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy
por: Li, Zhihua, et al.
Publicado: (2019)

The Role of the Food and Drug Administration in Drug Development: On the Subject of Proarrhythmia Risk
por: Thind, Munveer, et al.
Publicado: (2020)

Assessment of drug-induced proarrhythmias due to pilsicainide in patients with atrial tachyarrhythmias
por: Koike, Hideki, et al.
Publicado: (2016)

Necessity to evaluate PI3K/Akt signalling pathway in proarrhythmia
por: Ezeani, Martin, et al.
Publicado: (2017)

Right ventricular lead proarrhythmia: A novel intervention for an under-recognized phenomenon
por: Hayase, Justin, et al.
Publicado: (2017)

Electrical Restitution and Its Modifications by Antiarrhythmic Drugs in Undiseased Human Ventricular Muscle
por: Árpádffy-Lovas, Tamás, et al.
Publicado: (2020)

Experimental Pharmacology in Transgenic Rodent Models of Alzheimer’s Disease
por: Cuello, A. Claudio, et al.
Publicado: (2019)

Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis
por: Kovanda, Laura L., et al.
Publicado: (2019)

Automated Algorithm for J-T(peak) and T(peak)-T(end) Assessment of Drug-Induced Proarrhythmia Risk
por: Johannesen, Lars, et al.
Publicado: (2016)

Effect of hydroxychloroquine on proarrhythmia risk assessment using human iPSC-derived cardiomyocytes
por: Yanagida, Shota, et al.
Publicado: (2021)

CaMKII Serine 280 O-GlcNAcylation Links Diabetic Hyperglycemia to Proarrhythmia
por: Hegyi, Bence, et al.
Publicado: (2021)

Connexin diversity in the heart: insights from transgenic mouse models
por: Verheule, Sander, et al.
Publicado: (2013)

Non-invasive visualization of the complete cardiac conduction system using magnetic resonance microscopy
por: Hwang, Min-Sig, et al.
Publicado: (2011)

A comprehensive quantitative comparison of myocardial motion in mice, rabbits and humans using phase contrast MRI
por: Jung, Bernd A, et al.
Publicado: (2012)

SARS-CoV-2 spike protein-induced inflammation underlies proarrhythmia in COVID-19
por: Mezache, Louisa, et al.
Publicado: (2023)

A quantitative comparison of regional myocardial motion in mice, rabbits and humans using in-vivo phase contrast CMR
por: Jung, Bernd, et al.
Publicado: (2012)

Transgenic Animal Models to Visualize Cancer-Related Cellular Processes by Bioluminescence Imaging
por: Manni, Isabella, et al.
Publicado: (2019)

Proarrhythmia in the p.Met207Val PITX2c-Linked Familial Atrial Fibrillation-Insights From Modeling
por: Bai, Jieyun, et al.
Publicado: (2019)

Short-Long Heart Rate Variation Increases Dispersion of Action Potential Duration in Long QT Type 2 Transgenic Rabbit Model
por: Kim, Tae Yun, et al.
Publicado: (2019)

Neuroprotective Studies on Polygonum hydropiper L. Essential Oils Using Transgenic Animal Models
por: Tong, Xin, et al.
Publicado: (2021)

Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease
por: Caruso, Giuseppe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0gv1fukspheo9ndsn348ots8r2